JOINT FILING AGREEMENTJoint Filing Agreement • September 26th, 2022 • venBio Global Strategic Fund III, L.P. • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of CinCor Pharma, Inc. dated as of September 26, 2022 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
